NCT03719053View on ClinicalTrials.gov

Single Dose Truvada Study

PHASE1CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

October 25, 2018

Primary Completion Date

June 30, 2020

Study Completion Date

June 30, 2020

Conditions
Medication AdherenceHIV Prevention
Interventions
DRUG

Tenofovir

pre- and post-dosing measurements of TFV and TFV-DP in plasma and PBMCs.

Trial Locations (1)

21287

Johns Hopkins Hospital, Baltimore

All Listed Sponsors
lead

Johns Hopkins University

OTHER

NCT03719053 - Single Dose Truvada Study | Biotech Hunter | Biotech Hunter